Peer review of the pesticide risk assessment of the active substance triclopyr (variant triclopyr‐butotyl)

. 2024 Aug 12;22(8):e8177. doi: 10.2903/j.efsa.2024.8177

Properties		Conclusion ^a
CMR	Carcinogenicity (C)	Triclopyr is not considered to be a carcinogen according to point 3.6.3 of Annex II of Regulation (EC) No 1107/2009
	Mutagenicity (M)	Triclopyr is not considered to be a mutagen according to point 3.6.2 of Annex II of Regulation (EC) No 1107/2009
	Toxic for Reproduction (R)	Triclopyr is not considered to be toxic for reproduction according to point 3.6.4 of Annex II of Regulation (EC) No 1107/2009
Endocrine disrupting properties		Triclopyr does not meet the ED criteria for humans and non‐target organisms according to points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009, as amended by Commission Regulation (EU) 2018/605
POP	Persistence	Triclopyr is not considered to be a persistent organic pollutant (POP) according to point 3.7.1 of Annex II of Regulation (EC) 1107/2009
	Bioaccumulation
	Long‐range transport
PBT	Persistence	Triclopyr is not considered to be a persistent, bioaccumulative and toxic (PBT) substance according to point 3.7.2 of Annex II of Regulation (EC) 1107/2009
	Bioaccumulation
	Toxicity
vPvB	Persistence	Triclopyr is not considered to be a very persistent, very bioaccumulative substance according to point 3.7.3 of Annex II of Regulation (EC) 1107/2009
vPvB	Bioaccumulation

^{^a}

Origin of data to be included where applicable (e.g. EFSA, ECHA RAC, Regulation).